China Cancer Drugmaker Surges 28% in Hong Kong Trading Debut
Hutchmed (China) Ltd., a cancer drug developer backed by billionaire Li Ka-shing, jumped in its firs
Terms and Conditions·Privacy Policy
Company: TTMF Limited. Tech supported by Xiangshang Yixin.
Email:uservice@ttm.financial